Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 3
2021 2
2022 4
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
99mTc-labeled nanocolloid drugs: development methods.
Sadkin V, Sкuridin V, Nesterov E, Stasyuk E, Rogov A, Varlamova N, Zelchan R. Sadkin V, et al. Among authors: zelchan r. Sci Rep. 2020 Aug 19;10(1):14013. doi: 10.1038/s41598-020-70991-2. Sci Rep. 2020. PMID: 32814811 Free PMC article.
Comparative Preclinical Evaluation of Peptide-Based Chelators for the Labeling of DARPin G3 with 99mTc for Radionuclide Imaging of HER2 Expression in Cancer.
Larkina M, Plotnikov E, Bezverkhniaia E, Shabanova Y, Tretyakova M, Yuldasheva F, Zelchan R, Schulga A, Konovalova E, Vorobyeva A, Garousi J, Gräslund T, Belousov M, Tolmachev V, Deyev S. Larkina M, et al. Among authors: zelchan r. Int J Mol Sci. 2022 Nov 3;23(21):13443. doi: 10.3390/ijms232113443. Int J Mol Sci. 2022. PMID: 36362226 Free PMC article.
Phase I Study of 99mTc-ADAPT6, a Scaffold Protein-Based Probe for Visualization of HER2 Expression in Breast Cancer.
Bragina O, von Witting E, Garousi J, Zelchan R, Sandström M, Orlova A, Medvedeva A, Doroshenko A, Vorobyeva A, Lindbo S, Borin J, Tarabanovskaya N, Sörensen J, Hober S, Chernov V, Tolmachev V. Bragina O, et al. Among authors: zelchan r. J Nucl Med. 2021 Apr;62(4):493-499. doi: 10.2967/jnumed.120.248799. Epub 2020 Aug 17. J Nucl Med. 2021. PMID: 32817142 Free PMC article. Clinical Trial.
Phase I Trial of [99mTc]Tc-maSSS-PEG2-RM26, a Bombesin Analogue Antagonistic to Gastrin-Releasing Peptide Receptors (GRPRs), for SPECT Imaging of GRPR Expression in Malignant Tumors.
Chernov V, Rybina A, Zelchan R, Medvedeva A, Bragina O, Lushnikova N, Doroshenko A, Usynin E, Tashireva L, Vtorushin S, Abouzayed A, Rinne SS, Sörensen J, Tolmachev V, Orlova A. Chernov V, et al. Among authors: zelchan r. Cancers (Basel). 2023 Mar 7;15(6):1631. doi: 10.3390/cancers15061631. Cancers (Basel). 2023. PMID: 36980517 Free PMC article.
11 results